ORTEXORTEX News
Tracking CSWC? Get live short interest, options flow, and signals on ORTEX.Sign up free →
CS
Earnings PreviewCSWC

CSWC Heads Into Earnings With Borrow Tightening Fast

By ORTEX News · Edited by , Editor, ORTEX NewsUpdated 2 min readdata as of 3 Nov 2026, 04:20

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

Capital Southwest Corporation reports today with borrow availability shrinking sharply and short interest sitting at a meaningful level, even as the stock has rebounded over the past week.

The lending market tells the clearest story heading into the print. Availability has dropped to roughly 21%, meaning only about one share remains available to borrow for every four already lent out. That is a dramatic tightening: just two weeks ago, availability was above 95%, and on October 13 it hit a 52-week low of 0.5%, momentarily exhausting the entire lending pool. Cost to borrow has eased from that peak, falling around 14% over the past week to 8.3%, but the direction of travel in availability is still down. Short interest of 6.3% of the free float is material for a BDC, and days to cover at seven suggests any squeeze would take time to unwind. The ORTEX short score of 68.9 places the stock in the 6th percentile of its sector, a reading that reflects genuine bearish pressure in the lending market rather than noise.

The bull and bear cases for CSWC split along familiar BDC fault lines. Bulls point to the income profile: senior and subordinated debt investments in middle-market companies generating stable interest and dividend income, with supplemental dividends paid consistently each quarter at $0.06 per share. The dividend factor score ranks in the 99th percentile. Bears counter that the higher-than-average equity allocation introduces net investment income volatility, and that credit quality in a slower-growth environment could weigh on portfolio marks. The analyst consensus sits at hold, with a mean price target of $25.08, modestly above the current price of $23.43. UBS raised its target to $24 in early October while keeping a Neutral rating. Two other firms maintained Buy-equivalent ratings with targets of $25.50 and $26.00 after the prior quarter's print, suggesting some on the Street see room for upside if credit metrics hold.

Options positioning has shifted in an interesting direction. The put/call ratio of 2.39 sits slightly below its 20-day average of 2.57, down from levels above 3.0 in late September and early October. That drift toward a less defensive posture coincides with the stock's 4.6% gain over the past week and a 1.1% gain on the last session. The stock has essentially gone nowhere over the past month, down 0.4%, but the weekly rebound puts it broadly in line with BDC peers: PFLT gained 7.8%, NMFC 5.4%, and BCSF 7.0% over the same period, suggesting sector tailwinds rather than CSWC-specific buying. The one genuinely stock-specific signal is insider activity: a director made a small open-market purchase of $50,000 at $23.04 in early October, the only clean discretionary buy in the recent record.

The print will test whether the portfolio's credit quality and net investment income have held up well enough to justify the supplemental dividend programme and close the gap to analyst targets.

Stocks in this article

See the live data behind this article on ORTEX.

Open CSWC on ORTEX →

How this article was generated

Generated
3 Nov 2026, 05:24
Data as of
3 Nov 2026, 04:20
Prompt version
v1.0
Data sources
Short interestCost to borrowUtilizationOptions flowEarningsInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt Data

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.